Lombard, IL 6/25/09—Orochem Technologies, a supplier of sample preparation products for life science, has acquired Oligonet, a custom oligonucleotide synthesis business based in Gaithersburg, Maryland. Financial details were not disclosed. “We saw great synergy between the Orochem and Oligonet products and this acquisition helps us offer a complete line of products to our customers,” stated […]
San Diego, CA 7/1/09—Illumina has revised its forecast for the second quarter and year-end. The company now expects second-quarter revenues of approximately $161 million, compared to guidance of $168–$173 million (see IBO 5/15/09). Full-year revenues are now estimated to be $690–$720 million. Citing a sequential quarterly decline in array revenue for the change, Illumina highlighted […]
The growing volume and complexity of genomic research requires higher-throughput, higher-density techniques that can simultaneously capture multiple data points with greater sensitivity at a lower cost per point. Rare variant research, validation studies and biomarker discovery are among the applications that will directly benefit. Such advancements are also applicable to the development and application of […]
In calendar-year 2008 (CY08), total R&D spending in US dollars for 20 major analytical and life science instrument companies (see table, page 4) climbed 9.5% to $1.41 billion, compared to 10.9% growth in CY07. The median growth rate grew 60 basis points to 8.5% in CY08. The increase in R&D spending was primarily a result […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
